Provided by Tiger Trade Technology Pte. Ltd.

Chemomab Therapeutics Ltd.

2.16
+0.09004.35%
Post-market: 2.12-0.0400-1.85%16:10 EDT
Volume:114.19K
Turnover:242.62K
Market Cap:15.83M
PE:-2.15
High:2.20
Open:2.06
Low:2.04
Close:2.07
52wk High:4.12
52wk Low:1.35
Shares:7.33M
Float Shares:6.14M
Volume Ratio:2.02
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0070
EPS(LYR):-1.4103
ROE:-82.17%
ROA:-46.27%
PB:1.82
PE(LYR):-1.53

Loading ...

Chemomab Therapeutics Q2 Operating Expenses USD 2.241 Million

THOMSON REUTERS
·
Aug 19

Chemomab Q2 FY26 Net Loss Widens to $2.2 Million

Reuters
·
Aug 19

Chemomab Therapeutics Ltd - Nebokitug Ra Phase 2 Clinical Trial Expected to Begin in H1 2027 and Read Out in H1 2028

THOMSON REUTERS
·
Aug 19

Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 19

Chemomab Therapeutics Ltd - Cash, Cash Equivalents and Short-Term Bank Deposits were $6.7 Million as of June 30, 2026

THOMSON REUTERS
·
Aug 19

Chemomab Therapeutics Ltd Expected to Post a Loss of 15 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Genmab (GMAB)

TIPRANKS
·
Jul 15

Adrs End Lower; Chemomab Therapeutics Ltd. Declines 29%

Dow Jones
·
Jul 09

Top Midday Decliners

MT Newswires Live
·
Jul 09

Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an Ai-powered Phase 2 Trial in Rheumatoid Arthritis

THOMSON REUTERS
·
Jul 08

Chemomab: Combined Co Valued at $150 Mln Before Concurrent $30 Million Private Placement from Top- Tier Investors

THOMSON REUTERS
·
Jul 08

Chemomab Therapeutics: Combined Company to Operate as Scipher Medicine Corporation & Trade on NASDAQ Under Ticker Symbol “scip”

THOMSON REUTERS
·
Jul 08

Chemomab Therapeutics: Chemomab Shareholders to Own About 32% & Scipher Equity Holders Expected to Own About 68% of Combined Co Post-merger

THOMSON REUTERS
·
Jul 08

Chemomab: Co, Precision Medicine Pioneer Scipher Medicine Merger Deal to Advance Nebokitug in an Ai-powered Phase 2 Trial in Rheumatoid Arthritis

THOMSON REUTERS
·
Jul 08

Chemomab: Topline Readout of Ra Phase 2 Trial Results Expected in H1 2028

THOMSON REUTERS
·
Jul 08

Chemomab Agrees to Merge with Scipher Medicine in Stock Deal, Combined Firm to Trade as SCIP

Reuters
·
Jul 08

Chemomab appoints Gwen Melincoff to board, names her nominating committee chair

Reuters
·
Jun 03

Chemomab CEO Adi Mor George acquires 9,804 ADS worth $20,238.88

Reuters
·
Jun 01

Chemomab Therapeutics Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Chemomab Q1 FY26 net loss narrows to $1.8 million

Reuters
·
May 14